Sotera Health Company (SHC)
NASDAQ: SHCHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
SHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.11B
- P/E (TTM)
- 31.40
- Forward P/E
- 16.65
- EPS (TTM)
- $0.57
- Dividend yield
- None
- 52-week range
- 13.09 – 19.85
- Day range
- 17.87 – 18.69
- Volume / Avg
- 1.61M / 2.51M
- Beta
- —
- Shares outstanding
- 285.37M
- Next earnings
- Nov 3, 2026
52-week range
SHC stock today
Sotera Health (SHC) closed at $17.90 on Oct 7, down 1.92% (-$0.35), versus the S&P 500's 0.22% decline. At this level, SHC sits in the middle of its 52-week range of $13.09 to $19.85: 9.8% below the high, set on Jan 9, 2026 and 36.7% above the low. SHC is up 1.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 11.3%.
At 31.4x trailing earnings, Sotera Health trades above the peer-group median of 18.3x. Its forward P/E of 16.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Sotera Health's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Sotera Health
Company profileSotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Alton E. Shader
- Headquarters
- Broadview Heights, OH
- Employees
- 3,000
- IPO year
- 2020
- Website
- soterahealth.com
Financial highlights
Full financialsIn fiscal 2025, Sotera Health generated $1.16 billion in revenue, up 5.7% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $77.9 million (+75.6% year over year), for a net margin of 6.7% versus a median of 4.0% in the prior 5 years. Gross margin was 55.5% (up from 54.7%).
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.48M |
| Growth | +5.74% | +4.88% | +4.54% | +7.75% | +13.85% |
| Net income | $77.95M | $44.40M | $51.38M | $-233.57M | $116.88M |
| EPS (diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
Analyst forecast
ForecastConsensus (10 analysts)
buy
Avg. price target
$22.72+26.93%
- Strong buy 3
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $0.24
- Last reported (Q2 2026)
- Aug 6, 2026
- EPS actual vs est.
- $0.19 vs —
Sotera Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs SHC |
| AGLagilon health inc. | 85.70 | +2.76% | $1.44B | vs SHC |
| VMDViemed Healthcare Inc. | 9.37 | +0.43% | $356.89M | vs SHC |
| PARKPark Dental Partners Inc. | 20.94 | +1.26% | $99.58M | vs SHC |
| CCELCryo-Cell International Inc. | 3.91 | +0.77% | $31.52M | vs SHC |
| MGRXMangoceuticals Inc. | 0.4437 | -1.40% | $9.57M | vs SHC |
| NIVFNewGenIvf Group Limited Class A | 0.106 | +7.40% | $2.89M | vs SHC |
| FMSFresenius Medical Care AG ADR | 20.69 | -7.72% | $11.01B | vs SHC |
Indexes, lists and sector
Sotera Health stock FAQ
What is Sotera Health's stock price today?
SHC last traded at $17.90 as of Oct 7, 4:00 PM EDT, down 1.92% on the day. Prices are delayed at least 15 minutes.
When is Sotera Health's next earnings date?
Sotera Health is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.24.
What is SHC's P/E ratio?
SHC trades at a trailing P/E ratio of 31.40 and a forward P/E of 16.65, compared with a median of 18.3 for its closest peers.
Who is Sotera Health's CEO?
Mr. Alton E. Shader is the chief executive officer of Sotera Health Company, which has about 3,000 employees.
What is the SHC 52-week high?
The 52-week high for SHC is $19.85 and the 52-week low is $13.09. The stock is currently 9.8% below its high.